Notice NOT-AA-23-007 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-023 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-019 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-066 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-111 from the NIH Guide for Grants and Contracts. NIMHD invites applications to support short-term exploratory or developmental research projects that have the potential to break new ground in the fields of minority health and/or health disparities or extend previous discoveries toward new directions or applications that can directly contribute to improving minority health and/or reducing health disparities in the U.S.

Funding Opportunity RFA-EB-23-001 from the NIH Guide for Grants and Contracts. Ethical considerations are intrinsic to the conduct of robotic and bionic device research. This Funding Opportunity Announcement (FOA) invites applications that propose research on ethical questions associated with all stages of the design, testing, and/or implementation of bionic and robotic devices.

Funding Opportunity PAS-23-086 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement encourages the submission ofpilot and feasibilityclinical trialsconducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. The program will support small, short-term proof-of-concept clinical trials in humans to acquire preliminary data regarding the effects of the intervention, as well as feasibility data related to recruitment and retention, and study conduct. Applications for clinical trials submitted under this FOA should have clearly described aims and objectives, and have a high likelihood that the trial findings will lead to more definitive, hypothesis-driven trials to improve understanding, diagnosis, prevention or treatment of the diseases studied and have the potential to impact clinical practice and/or public health.Preliminary data regarding intervention efficacy are not required.

Notice NOT-HD-23-004 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-017 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-069 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-089 from the NIH Guide for Grants and Contracts. This FOA invites applications from multidisciplinary teams to perform secondary data analysis, using existing datasets from two or more multi-site clinical research projects, to address scientific and clinical hypotheses relevant to neurological disorders and conditions within the NINDS mission. In this phased funding mechanism, applications are required to systematically and comprehensively perform cross-project data harmonization and curation, assessed using Go/No-go data-quality metrics, prior to funding of the second phase of data analyses. Consistent with the FAIR (findable, accessible, interoperable and reusable) data principles, this funding opportunity expects open-source cataloging of the processes and tools used for harmonization, curation, and analysis, as well as controlled access to the curated datasets.

Funding Opportunity RFA-AG-24-018 from the NIH Guide for Grants and Contracts. This FOA invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to simultaneously address a targeted research question in brain aging and Alzheimer's disease (AD),including Alzheimer's disease related dementias (ADRD). This FOA will use the R21/R33 to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable interdisciplinary collaboration across experimental and computational laboratories to support projects that address key research questions in brain aging and AD/ADRD.

Notice NOT-HL-23-066 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-262 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.

Notice NOT-ES-23-005 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-068 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-042 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-074 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-074 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MD-23-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups who experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.